Skip to main content

Table 3 Participating medical centres and the inclusion estimations. The participating centres of the DOLPHIN trial, the date of the start of the study and the estimated inclusions in study sites

From: The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial

Study sites

Start date

Expected enrollment

Erasmus Medical Center (Rotterdam)

01–11–2018

100

Haaglanden Medical Center (The Hague)

01-07-2019

50

Haga Hospital (The Hague)

01-07-2019

50

Franciscus Gasthuis en Vlietland (Rotterdam)

01-07-2019

50

Amphia Hospital (Breda)

01-10-2019

50

Groene Hart Hospital (Gouda)

01-12-2019

50

Isala Hospital (Zwolle)

01-12-2019

50

Diakonessenhuis (Utrecht)

01–01–2020

50